Skip to content
Biodatica
Start free

Sarcoma Alliance for Research through Collaboration

Los Angeles, California

OncologyPhase II
Compare Sign in to watch

What changed

Study registered, no phase assigned: Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

1w agoTrial registeredJul 8, 2026Source filing (opens the source filing in a new tab)

Momentum

81no change

Momentum 81 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

1,845 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE1/PHASE2 registered

    Jan 5, 2021

    Ewing Sarcoma · COMPLETED · sponsor: Sarcoma Alliance for Research through Collaboration · SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients

    ClinicalTrials.gov · NCT04067115 (opens the source filing in a new tab)

  2. Trial

    PHASE2 registered

    Aug 16, 2017

    Paraganglioma, Gastrointestinal Stromal Tumors, Carcinoma, Renal Cell, Renal Neoplasms, Pheochromocytoma · TERMINATED · sponsor: National Cancer Institute (NCI) · A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer

    ClinicalTrials.gov · NCT03165721 (opens the source filing in a new tab)

  3. Trial

    Study registered

    Dec 5, 2006

    Diffuse Intrinsic Pontine Glioma, PNET, Ependymoma, Germinoma, Medulloblastoma · COMPLETED · sponsor: National Cancer Institute (NCI) · Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

    ClinicalTrials.gov · NCT01445288 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources